Home / Immunology
Immunology
| 2 min read
Trinity College Dublin researchers report a nasal vaccine that prevented infection and spread of pertussis in preclinical models.
| 2 min read
Acquisition brings Avidity’s RNA delivery platform and late-stage neuromuscular programs under Novartis, expanding its capabilities in developing precision genetic medicines.
| 2 min read
ImmunoVec will use a $40.7 million grant to advance its polymeric nanoparticle platform toward a first-in-human trial for autoimmune diseases.
| 2 min read
New study identifies fibroblast subtypes as potential universal drug targets in cancer, skin, and inflammatory diseases.
| 2 min read
Nearly 25 percent of non-antibiotic drugs tested in the study enabled the proliferation of enteropathogens.
| 9 min read
Scientists are advancing CAR T cell therapy to improve outcomes for children with acute lymphoblastic leukemia.
| 3 min read
Papzimeos is the first FDA-approved therapy for recurrent respiratory papillomatosis, a rare HPV-driven disease that has long forced patients into repeated surgeries.
| 3 min read
Final results from the AMPLIFY-201 phase 1 trial highlight durable T cell responses and prolonged survival in patients with colorectal and pancreatic cancer.
Available on Demand
Discover how coculture models and CRISPR tools reveal new insights into tumour microenvironments.
| 6 min read
Macrophage-based therapies for liver cirrhosis are entering clinical trials, but key challenges remain before they become a viable treatment.
Available on Demand
Explore how combining human immune and epithelial or cancer cells in vitro enhances predictive power in infectious disease and oncology research.
| 4 min read
In vivo CAR T, lab-grown eggs, trial access, postpartum depression, and RNA therapy for hereditary angioedema led drug discovery this week.
